Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ibudilast by MediciNova for Chemotherapy Induced Peripheral Neuropathy: Likelihood of Approval
Ibudilast is under clinical development by MediciNova and currently in Phase II for Chemotherapy Induced Peripheral Neuropathy. According to GlobalData,...
Ibudilast by MediciNova for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome: Likelihood of Approval
Ibudilast is under clinical development by MediciNova and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory...
Ibudilast by MediciNova for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Ibudilast is under clinical development by MediciNova and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia. According to...